ERBB2 and gastric cancer: Together, our findings therefore suggest that autophagy played a cytoprotective role and the combination of T-DM1 and autophagy inhibitors represents an effective strategy to achieve potent therapeutic efficacy for T-DM1-based therapy in HER2-positive GC.